Relationship between structural features and in vitro release of doxorubicin from biocompatible anionic microemulsion

被引:38
作者
Formariz, T. P.
Chiavacci, L. A.
Sarmento, V. H. V.
Santilli, C. V.
do Egito, E. S. Tabosa
Oliveira, A. G.
机构
[1] UNESP, Fac Ciencias Farmaceut, Dept Farm & Med, BR-14801902 Araraquara, SP, Brazil
[2] UNESP, Inst Quim, Dept Quim Fis, BR-14800900 Araraquara, SP, Brazil
[3] Univ Fed Rio Grande do Norte, Ctr Ciencias Saude, Dept Farm, BR-59010180 Natal, RN, Brazil
基金
巴西圣保罗研究基金会;
关键词
anionic microemulsion; mesophases; drug delivery; doxorubicin; SAXD; XRD;
D O I
10.1016/j.colsurfb.2007.05.017
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
In this work structural features of anionic microemulsions, containing the pharmaceutical biocompatible components soya phosphatidylcholine (SPC), eumulgin HRE 40 (EU) and sodium oleate (SO) as surfactant, cholesterol (CHO) as oil phase and aqueous buffer were studied. Microemulsions were formulated with and without the antitumor drug doxorubicin (DOX). The various microstructures characterized in the pseudo-temary phase diagram were analyzed by polarized light microscopy, small-angle X-ray scattering (SAXS) and X-ray diffraction (XRD) as well as by their ability to incorporate and release DOX. The experimental results demonstrated a correlation between the composition, the structural features and drug delivery. It was found that at higher cholesterol contents, the crystallization of CHO polymorph phases changed the mobility of DOX molecules. Droplets were formed with short-range spatial correlation from a microemulsion (ME) with a low surfactant:oil ratio. More ordered structures with lamellar arrangements formed by the increasing of the CHO proportions in the formulation may be due to CHO crystallization. The in vitro release of DOX showed that the presence of a high content of crystalline CHO prolongs the release of DOX from ME. The retention of DOX in the internal oil phase of the ME may modulate the drug release for a prolonged time. These results clearly demonstrate the potential of ME as a drug-delivery system. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:28 / 35
页数:8
相关论文
共 31 条
[1]  
AHMAD I, 1993, CANCER RES, V53, P1484
[2]   LONG-CIRCULATING (STERICALLY STABILIZED) LIPOSOMES FOR TARGETED DRUG-DELIVERY [J].
ALLEN, TM .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1994, 15 (07) :215-220
[3]   Microemulsions for topical delivery of 8-methoxsalen [J].
Baroli, B ;
López-Quintela, MA ;
Delgado-Charro, MB ;
Fadda, AM ;
Blanco-Méndez, J .
JOURNAL OF CONTROLLED RELEASE, 2000, 69 (01) :209-218
[4]  
BEAUCAGE G., 1995, HYBRID ORGANIC INORG
[5]   Percutaneous absorption of sunscreens from liquid crystalline phases [J].
Brinon, L ;
Geiger, S ;
Alard, V ;
Doucet, J ;
Tranchant, JF ;
Couarraze, G .
JOURNAL OF CONTROLLED RELEASE, 1999, 60 (01) :67-76
[6]   Binding of drugs to monoglyceride-based drug delivery systems [J].
Chang, CM ;
Bodmeier, R .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 147 (02) :135-142
[7]  
CORREA MA, 2005, COLLOID SURFACE B, V43, P114
[8]  
CORREA MA, 2005, COLLOID SURFACE B, V43, P112
[9]   Inclusion complex of piroxicam with β-cyclodextrin and incorporation in cationic microemulsion.: In vitro drug release and in vivo topical anti-inflammatory effect [J].
Dalmora, ME ;
Dalmora, SL ;
Oliveira, AG .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 222 (01) :45-55
[10]   Inclusion complex of piroxicam with β-cyclodextrin and incorporation in hexadecyltrimethylammonium bromide based microemulsion [J].
Dalmora, MEA ;
Oliveira, AG .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 184 (02) :157-164